Literature DB >> 28692051

Transcriptional regulation of ataxia-telangiectasia and Rad3-related protein by activated p21-activated kinase-1 protects keratinocytes in UV-B-induced premalignant skin lesions.

S Beesetti1, J Mavuluri1, R P Surabhi1, T M Oberyszyn2, K Tober2, R S Pitani3, L D Joseph4, G Venkatraman5, S K Rayala1.   

Abstract

Sun-induced skin lesions, in particular actinic keratosis, are generally considered as premalignant skin lesions that can progress into squamous cell carcinoma (SCC) and invasive SCC if left untreated. Therefore, understanding the molecular mechanisms by which the ultraviolet-B (UV-B)-exposed cells are being protected and the signaling pathways that promote the progression of certain premalignant skin lesions to malignant lesions will permit us to prevent or cure skin cancers. In the current study, we found that phospho-p21-activated kinase-1 (Pak1) and Pak1 expression was high in clinical samples of sunlight-induced premalignant skin lesions assessed by immunohistochemistry. Further, we observed that phospho-Pak1 and Pak1 levels are high in UV-B-exposed hairless SKH mouse model skin samples as compared with unexposed skin tissue. Our results from cell line and animal models showed that Pak1 is activated in response to UV-B radiation, and this activated Pak1 translocates from the cytoplasm to the nucleus. Inside the nucleus, Pak1 via C-Fos binds to a specific promoter region of DNA repair kinase ATR (ataxia-telangiectasia and Rad3-related protein) and acts as a transcriptional regulator of ATR. Results from our analysis showed that Pak1 overexpression, knockdown and Pak1 knockout cell line models showed that Pak1 confers protection to keratinocytes from UV-B-induced apoptosis and DNA damage via ATR. To our knowledge, this is the first study that evaluates the functional and clinical significance of a signaling molecule, Pak1, in sun-induced premalignant skin lesions and indicates that increased Pak1 activation and expression could serve as an early warning sign of progression toward non-melanoma skin cancer, if ignored.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28692051     DOI: 10.1038/onc.2017.218

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  42 in total

1.  Assessment of the feasibility of using sunlight exposure to obtain the recommended level of vitamin D in Canada.

Authors:  Pavandeep Gill; Sunil Kalia
Journal:  CMAJ Open       Date:  2015-07-17

Review 2.  PAK signalling during the development and progression of cancer.

Authors:  Maria Radu; Galina Semenova; Rachelle Kosoff; Jonathan Chernoff
Journal:  Nat Rev Cancer       Date:  2014-01       Impact factor: 60.716

Review 3.  Epidemiology of nonmelanoma skin cancer: a review.

Authors:  R Corona
Journal:  Ann Ist Super Sanita       Date:  1996       Impact factor: 1.663

4.  Nuclear localization and chromatin targets of p21-activated kinase 1.

Authors:  Rajesh R Singh; Chunying Song; Zhibo Yang; Rakesh Kumar
Journal:  J Biol Chem       Date:  2005-03-03       Impact factor: 5.157

5.  The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 (Iressa) suppresses c-Src and Pak1 pathways and invasiveness of human cancer cells.

Authors:  Zhibo Yang; Rozita Bagheri-Yarmand; Rui-An Wang; Liana Adam; Vali Vassiliki Papadimitrakopoulou; Gary L Clayman; Adel El-Naggar; Reuben Lotan; Christopher J Barnes; Waun Ki Hong; Rakesh Kumar
Journal:  Clin Cancer Res       Date:  2004-01-15       Impact factor: 12.531

6.  c-Fos is involved in the cellular defence against the genotoxic effect of UV radiation.

Authors:  S Haas; B Kaina
Journal:  Carcinogenesis       Date:  1995-05       Impact factor: 4.944

7.  p21-Activated kinase 1 is required for efficient tumor formation and progression in a Ras-mediated skin cancer model.

Authors:  Hoi Yee Chow; Adrian M Jubb; Jennifer N Koch; Zahara M Jaffer; Dina Stepanova; David A Campbell; Sergio G Duron; Marie O'Farrell; Kathy Q Cai; Andres J P Klein-Szanto; J Silvio Gutkind; Klaus P Hoeflich; Jonathan Chernoff
Journal:  Cancer Res       Date:  2012-09-14       Impact factor: 12.701

8.  Common DNA binding site for Fos protein complexes and transcription factor AP-1.

Authors:  F J Rauscher; L C Sambucetti; T Curran; R J Distel; B M Spiegelman
Journal:  Cell       Date:  1988-02-12       Impact factor: 41.582

Review 9.  Cellular functions regulated by phosphorylation of EGFR on Tyr845.

Authors:  Ken-Ichi Sato
Journal:  Int J Mol Sci       Date:  2013-05-23       Impact factor: 5.923

Review 10.  The role of p21-activated kinases in hepatocellular carcinoma metastasis.

Authors:  Edith Yuk Ting Tse; Yick Pang Ching
Journal:  J Mol Signal       Date:  2014-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.